Evidence map›Paper›PMID 23537369›Full record

ReviewMolecular pain2013

Preclinical studies of low back pain.

Judith A Strong, Wenrui Xie, Feguens J Bataille, Jun-Ming Zhang

Abstract readReview
In one paragraph

Review in Molecular pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Role of NaNeuroscience · 2019
    Article
  11. Article
  12. Animal models for studying the etiology and treatment of low back pain.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Review
  13. Article
  14. Article
  15. Neuropathic low back pain in clinical practice.European journal of pain (London, England) · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Judith A StrongPain Research Center, Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0531, USA.
Wenrui Xie
Feguens J Bataille
Jun-Ming Zhang

Funding

STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTINGR01NS045594 · NINDS · UNIVERSITY OF CINCINNATI · PI ZHANG, JUN-MING · 2004 to 2025
$8.6M
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAINR01NS055860 · NINDS · UNIVERSITY OF CINCINNATI · PI ZHANG, JUN-MING · 2008 to 2017
$3.7M
NINDS NIH HHS NS45594NINDS NIH HHS NS55860NINDS NIH HHS R01 NS045594NINDS NIH HHS R01 NS055860
6 · The paper itself

Abstract

Chronic low back pain is a major cause of disability and health care costs. Current treatments are inadequate for many patients. A number of preclinical models have been developed that attempt to mimic aspects of clinical conditions that contribute to low back pain. These involve application of nucleus pulposus material near the lumbar dorsal root ganglia (DRG), chronic compression of the DRG, or localized inflammation of the DRG. These models, which are primarily implemented in rats, have many common features including behavioral hypersensitivity of the hindpaw, enhanced excitability and spontaneous activity of sensory neurons, and locally elevated levels of inflammatory mediators including cytokines. Clinically, epidural injection of steroids (glucocorticoids) is commonly used when more conservative treatments fail, but clinical trials evaluating these treatments have yielded mixed results. There are relatively few preclinical studies of steroid effects in low back pain models. One preclinical study suggests that the mineralocorticoid receptor, also present in the DRG, may have pro-inflammatory effects that oppose the activation of the glucocorticoid receptor. Although the glucocorticoid receptor is the target of anti-inflammatory steroids, many clinically used steroids activate both receptors. This could be one explanation for the limited effects of epidural steroids in some patients. Additional preclinical research is needed to address other possible reasons for limited efficacy of steroids, such as central sensitization or presence of an ongoing inflammatory stimulus in some forms of low back pain.

Indexed as

Disease Models, AnimalAnimalsAnti-Inflammatory AgentsBehavior, AnimalHumansInflammationLow Back PainNeuronsAnti-Inflammatory Agents

Identifiers

PMID23537369
PMCPMC3617092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.